FDAnews Device Daily Bulletin

CARETEK MEDICAL OBTAINS FUNDING FOR NEEDLE-FREE INJECTIONS

Dec. 15, 2005
A A

British company Caretek Medical, which is developing an innovative needle-free drug delivery device, has completed an oversubscribed 2.1 million funding round in just four weeks.

Pharmaceutical partners looking to combine the novel delivery system with their own proprietary drugs are already investigating Caretek's patented ImplaJect device, which is the size of a fountain pen and uses a spring mechanism to deliver drugs through the skin in a solid dosage form. Caretek will use the new capital to fund development of the ImplaJect technology through clinical trials of its first "own brand" product that will combine the device with well-established generic drugs.

The needle-free ImplaJect device delivers drugs through the skin into the underlying tissue where the drugs dissolve and are released into the patient's bloodstream.